NCT06630169View on ClinicalTrials.gov

Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Corneal Edema

Interventions

COMBINATION_PRODUCT

Cryopreserved AURN001

Corneal Endothelial Cells and Y27632

Trial Locations (1)

Unknown

Aurion Biotech site, San Salvador

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Aurion Biotech

INDUSTRY